Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
View Scopus Profile
Yun Yen
University Chair Professor
,
Master Program in Graduate Institute of Cancer Biology and Drug Discovery
Member
,
TMU Research Center of Cell Therapy and Regeneration Medicine
https://orcid.org/0000-0003-0815-412X
Email
yyen
tmu.edu
tw
h-index
18984
Citations
67
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
1994 …
2025
Research activity per year
Overview
Fingerprint
Network
Projects
(47)
Research output
(362)
Datasets
(7)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Yun Yen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
86%
Ribonucleotide Reductase
74%
Neoplasm
50%
Gemcitabine
28%
Breast Cancer
28%
Liver Cell Carcinoma
25%
Pharmacokinetics
25%
Biological Marker
22%
Disease
22%
Solid Malignant Neoplasm
21%
Hydroxycarbamide
20%
Nanoparticle
18%
Phase I Trials
16%
Mouse
16%
Overall Survival
16%
Camptothecin
15%
Tumor Growth
15%
Chemotherapy
15%
Small Interfering RNA
15%
Maximum Tolerated Dose
13%
Fibroblast Growth Factor Receptor 3
13%
Protein P53
12%
Clinical Trial
12%
Carcinogenesis
12%
Non Small Cell Lung Cancer
11%
Doxorubicin
11%
Bile Duct Carcinoma
10%
3 Aminopicolinaldehyde Thiosemicarbazone
10%
Cisplatin
10%
microRNA
10%
Multiple Myeloma
10%
Progression Free Survival
10%
Carboplatin
9%
Pancreas Cancer
9%
High Dose Chemotherapy
9%
Pharmacodynamics
9%
Anticarcinogen
9%
Drug Resistance
9%
Phase II Trials
9%
Colorectal Cancer
8%
Vasculotropin
8%
Bortezomib
7%
Oxaliplatin
7%
Histone Deacetylase Inhibitor
7%
Prostate Cancer
7%
Cyclodextrin
7%
Antitumor Activity
7%
Colon Cancer
6%
Holoenzyme
6%
Western Blot
6%
Biochemistry, Genetics and Molecular Biology
Ribonucleotide Reductase
100%
Cancer Cell
63%
Messenger RNA
23%
P53
23%
RRM2
19%
DNA Repair
17%
Hydroxycarbamide
16%
Gemcitabine
16%
Small Interfering RNA
16%
Carcinogenesis
14%
High-Mobility Group
13%
RRM2B
13%
Gene Expression
12%
Cell Proliferation
12%
Mouse
12%
Autophagy
12%
Drug Resistance
12%
Enzyme
12%
MicroRNA
12%
Oxidative Stress
11%
Promoter Region
11%
DNA Damage
11%
DNA Replication
11%
Cytotoxicity
10%
Wild Type
10%
Stem Cell
9%
Histone Deacetylase
9%
RNA
8%
Homeostasis
8%
Phosphotransferase
8%
Kinase
8%
Colon
8%
Overall Survival
8%
DNA Synthesis
8%
DNA Damage Checkpoint
8%
Arginine
7%
Cell Survival
7%
Cell Cycle
7%
Metabolite
7%
DNA Damage Response
6%
Signal Transduction
6%
Enzyme Activity
6%
Clinical Trial
6%
Ribonucleotide Reductase Inhibitor
6%
Tumor Progression
6%
Mitochondrion
6%
Tumor Suppressor Protein
6%
Cell Growth
6%
Microarrays
6%
Small Molecule
6%
Medicine and Dentistry
Malignant Neoplasm
38%
Breast Cancer
31%
Neoplasm
30%
Ribonucleotide Reductase
23%
Cancer Cell
22%
Hepatocellular Carcinoma
21%
Biological Marker
18%
Cholangiocarcinoma
17%
Disease
15%
Carcinogenesis
13%
Arginine
13%
Cancer
13%
Signal Transduction
13%
Metastatic Carcinoma
12%
Overall Survival
11%
microRNA
10%
In Vitro
10%
Non Small Cell Lung Cancer
10%
Clinical Trial
9%
Programmed Cell Death
9%
Stem Cell
9%
High Dose Chemotherapy
8%
Radiation Therapy
8%
Immunohistochemistry
8%
Hepatobiliary Cancer
7%
Fibroblast Growth Factor Receptor 3
7%
Gemcitabine
7%
Autophagy
7%
Recurrent Disease
7%
Histone Deacetylase Inhibitor
7%
Colorectal Cancer
7%
Antineoplastic Activity
6%
Drug Therapy
6%
Cisplatin
6%
Prostate Cancer
6%
Tumor Progression
6%
Triple Negative Breast Cancer
6%
Protein P53
6%
Gene Expression
5%
Oral Implants
5%
Pancreas Cancer
5%
Epidermal Growth Factor Receptor
5%
Adenocarcinoma
5%
Tumor Cell
5%
Progression Free Survival
5%
Diagnosis
5%
Cell Line
5%
Targeted Therapy
5%
Vasculotropin
5%
Stomach Cancer
5%
